AriaDx Provides Modular Solution for Diagnostic Labs and Assay Developers SANTA CLARA, Calif., July 25, 2017 Agilent Technologies Inc. (NYSE: A) today expanded its portfolio of instruments for molecular diagnostics with the introduction of the AriaDx Real-Time PCR System. AriaDx is the only modular real-time PCR instrument on the market intended for in vitro diagnostic... Read more
Molecular and Sample Barcoding IP Portfolio Bolsters Agilent’s Leadership Position in NGS Target Enrichment Solutions IP Portfolio Aimed at Improving Accuracy and Sensitivity of NGS Detection SANTA CLARA, Calif., July 24, 2017 Agilent Technologies Inc. (NYSE: A) (“Agilent”) today announced that it has acquired the molecular and sample barcoding patent portfolios of Population Genetics Technologies... Read more
CEO of Juno Therapeutics brings deep knowledge of the biopharma industry SANTA CLARA, Calif., July 18, 2017 Agilent Technologies, Inc. (NYSE: A) today announced that Hans E. Bishop, CEO of Juno Therapeutics, has been elected to its board of directors. Bishop co-founded Juno Therapeutics, a Seattle-based biopharmaceutical company, in 2013. As president and CEO, Bishop... Read more
Influential MIT Researcher Recognized for Advancing the Use of Analytical Techniques and Multilayer Analysis for Characterization of Biopharmaceuticals SANTA CLARA, Calif., July 18, 2017 Agilent Technologies Inc. (NYSE: A) today announced that Ram Sasisekharan, Ph.D., has received an Agilent Thought Leader Award in recognition of his contributions in the field of biologics characterization. A more... Read more
New Solution Streamlines Workflow and Eliminates Sequencing Errors SANTA CLARA, Calif., July 17, 2017 Agilent Technologies Inc. (NYSE: A) today introduced its newest next-generation sequencing (NGS) library prep solution — Agilent SureSelectXT HS — a complete target enrichment research solution that provides total workflow management for laboratories, from QC to target enrichment, to analysis and... Read more
Washington University in St. Louis Professor Recognized for Groundbreaking Work in Metabolomics SANTA CLARA, Calif., July 10, 2017 Agilent Technologies Inc. (NYSE: A) has named Dr. Gary J. Patti, as the recipient of the prestigious 2017 Agilent Early Career Professor Award. Dr. Patti, Associate Professor, Department of Chemistry in Arts & Sciences, Washington University in... Read more
WALDBRONN, Germany, July 7, 2017 Agilent Technologies Inc. (NYSE: A), today celebrated the opening of a new Agilent Customer and Technology Center at the Agilent campus in Waldbronn, Germany. Agilent executives were accompanied at the event by Katrin Schütz, state secretary in the Ministry of Economic Affairs, Labor, and Housing for the state of Baden-Württemberg;... Read more
Cobalt’s portfolio of solutions accelerates entry into high-growth Raman spectroscopy market and expands Agilent’s value proposition for pharmaceutical and biopharma customers SANTA CLARA, Calif., July 7, 2017 Agilent Technologies Inc. (NYSE: A) today announced it has acquired Oxfordshire, U.K.-based Cobalt Light Systems (“Cobalt”), a provider of highly differentiated Raman spectroscopic instruments for the pharmaceutical industry,... Read more
SANTA CLARA, Calif., June 19, 2017 Agilent Technologies Inc. (NYSE: A) today announced the introduction of several new products to complete the InfinityLab LC series, part of the InfinityLab family of instruments, columns, and supplies that work seamlessly together, alongside Agilent OpenLAB software and Agilent CrossLab services, to provide highly efficient workflows for customers. The... Read more
PD-L1 IHC 28-8 pharmDx Will Give More Insight to Which Patients with Urothelial Cancer are Most Likely to Benefit from Opdivo (nivolumab) SANTA CLARA, Calif., June 16, 2017 Agilent Technologies Inc. (NYSE: A) today announced expanded access to a clinically validated test for PD-L1 (programmed death-ligand 1), that will help physicians in Europe make more... Read more